Human tissue kallikreins: A new enzymatic cascade pathway?

Biological Chemistry

Volumn 383, Issue 7-8, 2002, Pages 1045-1057

  Yousef, George M ^a   Diamandis, Eleftherios P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Cascade activation system; Enzymatic activity; Kallikrein; Serine proteases; Tumor markers

Indexed keywords

CHYMOTRYPSIN; DNA; ENZYME PRECURSOR; MESSENGER RNA; PLASMA KALLIKREIN; PROTEINASE; SERINE PROTEINASE; STEROID HORMONE; TISSUE KALLIKREIN; TRYPSIN;

AMINO TERMINAL SEQUENCE; BREAST; CARCINOGENESIS; CATALYSIS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENDOMETRIUM; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENETIC TRAIT; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SALIVARY GLAND; TESTIS; TISSUE SPECIFICITY; ANIMAL; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALS; HUMANS; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION; TISSUE KALLIKREINS;

EID: 0036661263     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.113     Document Type: Review

References (131)

1. Akiyama, K., Nakamura, T., Iwanaga, S., and Hara, M. (1987). The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein. FEBS Lett. 225, 168-172.
2. Anisowicz, A., Sotiropoulou, G., Stenman, G., Mok, S. C., and Sager, R. (1996). A novel protease homolog differentially expressed in breast and ovarian cancer. Mol. Med. 2, 624-636.
3. Asakai, R., Davie, E. W. and Chung, D. W. (1987). Organization of the gene for human factor XI. Biochemistry 26, 7221-7228.
4. Bhoola, K. D., Figueroa, C. D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
5. Bhoola, K., Ramsaroop, R., Plendl, J., Cassim, B., Diamini, Z., and Naicker, S. (2001). Kallikrein and kinin receptor expression in inflammation and cancer. Biol. Chem. 382, 77-89.
6. Brattsand, M., and Egelrud, T. (1999). Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem. 274, 30033-30040.
7. Brillard-Bourdet, M., Moreau, T., and Gauthier, F. (1995). Substrate specificity of tissue kallikreins: importance of an extended interaction site. Biochim. Biophys. Acta 1246, 47-52.
8. Brookes, D. E., Zandvliet, D., Waft, F., Russell, P, J., and Molloy, P. L. (1998). Relative activity and specificity of promoters from prostate-expressed genes. Prostate 35, 18-26.
9. Chang, A., Yousef, G. M., Jung, K., Meyts, E. R., and Diamanids, E. P. (2001). Identification and molecular characterization of five novel kallikrein gene 13 (KLK13;KLK-L4) splice variants: differential expression in human testis and testicular cancer. Anticancer Res. 21, 147-152.
10. Chang, A., Yousef, G. M., Scorilas, A., Grass, L., Sismondi, P., Ponzone, R., and Diamandis, E. P. (2002). Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favorable prognosis in breast cancer. Br. J. Cancer, in press.
11. Chen, L. M., Murray, S. R., Chai, K. X., Chao, L., and Chao, J., (1994). Molecular cloning and characterization of a novel kallikrein transcript in colon and its distribution in human tissues. Braz. J. Med. Biol. Res. 27, 1829-1838.
12. Christensson, A., Laurell, C. B., and Lilja, H. (1990). Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem. 194, 755-763.
13. Christensson, A., Bjork, T., Nilsson, O., Dahlen, U., Matikainen, M. T., Cockett, A. T., Abrahamsson, P. A., and Lilja, H. (1993). Serum prostate specific antigen complexed to α 1-antichymotrypsin as an indicator of prostate cancer. J. Urol. 150, 100-105.
14. Christensson, A., and Lilja, H. (1994). Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem. 220, 45-53.
15. Clements, J. (1997). The molecular biology of the kallikreins and their roles in inflammation. In: The Kinin System, S. Farmer, ed. (New York, USA: Academic Press), pp. 71-97.
16. Clements, J., Hooper, J., Dong, Y., and Harvey, T. (2001). The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions. Biol. Chem. 382, 5-14.
17. Cleutjens, K. B., van Eekelen, C. C., van der Korput, H. A., Brinkmann, A. O., and Trapman, J. (1996). Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J. Biol. Chem. 271, 6379-6388.
18. Cleutjens, K. B., van der Korput, H. A., van Eekelen, C. C., van Rooij, H. C., Faber, P. W., and Trapman, J. (1997). An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol. 11, 148-161.
19. Cohen, P., Graves, H. C., Peehl, D. M., Kamarei, M., Giudice, L.C., and Rosenfeld, R.G. (1992). Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab. 75, 1046-1053.
20. Dayhoff, M. O. (1978). Atlas of protein sequence and structure. Natl. Biomed. Res. Found. 5, 79-81.
21. Denmeade, S. R., Lovgren, J., Khan, S. R., Lilja, H., and Isaacs, J. T. (2001). Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing. Prostate 48, 122-126.
22. Deperthes, D., Frenette, G., Brillard-Bourdet, M., Bourgeois, L., Gauthier, F., Tremblay, R. R., and Dube, J. Y. (1996). Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. J. Androl. 17, 659-665.
23. Dhar, S., Bhargava, R., Yunes, M., Li, B., Goyal, J., Naber, S. P., Wazer, D. E., and Band, V. (2001). Analysis of normal epitheliall cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin. Cancer Res. 7, 3393-3398.
24. Diamandis, E. P. (1998). Prostate-specific antigen-its usefulness in clinical medicine. Trends Endocrinol. Metab. 9, 310-316.
25. Diamandis, E. P., and Yousef, G. M. (2001). Human tissue kallikrein gene family:a rich source of novel disease biomarkers. Expert Rev. Mol. Diagn. 1, 182-190.
26. Diamandis, E. P., Yousef, G. M., Clements, J., Ashworth, L. K., Yoshida, S., Egelrud, T., Nelson, P. S., Shiosaka, S., Little, S., Lilia, H., Stenman, U. H., Rittenhouse, H. G., and Wain, H. (2000a). New nomenclature for the human tissue kallikrein gene family. Clin. Chem. 46, 1855-1858.
27. Diamandis, E. P., Yousef, G. M., Luo, L. Y., Magklara, A., and Obiezu, C. V. (2000b). The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab. 11, 54-60.
28. Diamandis, E. P., Yousef, G. M., Soosaipillai, A. R., and Bunting, P. (2000c). Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin. Biochem. 33, 579-583.
29. Diamandis, E. P., Yousef, G. M., Soosaipillai, A. R., Grass, L., Porter, A., Little, S., and Sotiropoulou, G. (2000d). Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin. Biochem. 33, 369-375.
30. Diamandis, E. P., Okui, A., Mitsui, S., Luo, L. Y., Soosaipillai, A., Grass, L., Nakamura, T., Howarth, D. J., and Yamaguchi, N. (2002). Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res. 62, 295-300.
31. Dong, Y., Kaushal, A., Bui, L., Chu, S., Fuller, P. J., Nicklin, J., Samaratunga, H., and Clements, J. A. (2001). Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin. Cancer Res. 7, 2363-2371.
32. Egelrud, T., and Lundstrom, A. (1990). The dependence of detergent-induced cell dissociation in non-palmo-plantar stratum corneum on endogenous proteolysis. J. Invest. Dermatol. 95, 456-459.
33. Evans, B. A., Drinkwater, C. C., and Richards, R. I. (1987). Mouse glandular kallikrein genes. Structure and partial sequence analysis of the kallikrein gene locus. J. Biol. Chem. 262, 8027-8034.
34. Evans, B. A., Yun, Z. X., Close, J. A., Tregear, G. W., Kitamura, N., Nakanishi, S., Callen, D. F., Baker, E., Hyland, V. J., Sutherland, G. R. et al. (1988). Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry 27, 3124-3129.
35. Farmer, G., Connolly, E. S., Jr., Mocco, J., and Freedman, L. P. (2001). Molecular analysis of the prostate-specific antigen upstream gene enhancer. Prostate 46, 76-85.
36. Fukushima, D., Kitamura, N., and Nakanishi, S. (1985). Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry 24, 8037-8043.
37. Goyal, J., Smith, K. M., Cowan, J. M., Wazer, D. E., Lee, S. W., and Band, V. (1998). The role for NES1 serine protease as a novel tumor suppressor. Cancer Res. 58, 4782-4786.
38. Halprin, K. M. (1972). Epidermal turnover time are-examination. Br. J. Dermatol. 86, 14-19.
39. Hansson, L., Stromqvist, M., Backman, A., Wallbrandt, P., Carlstein, A., and Egelrud, T. (1994). Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem. 269, 19420-19426.
40. Heidtmann, H. H., Nettelbeck, D. M., Mingels, A., Jager, R., Welker, H. G., and Kontermann, R. E. (1999). Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. Br. J. Cancer 81, 1269-1273.
41. Heuze, N., Olayat, S., Gutman, N., Zani, M. L., and Courty, Y. (1999). Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen. Cancer Res. 59, 2820-2824.
42. Hooper, J. D., Bui, L. T., Rae, F. K., Harvey, T. J., Myers, S. A., Ashworth, L. K., and Clements, J. A. (2001). Identification and characterization of klk14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle. Genomics 73, 117-122.
43. Hu, J. C., Zhang, C., Sun, X., Yang, Y., Cao, X., Ryu, O., and Simmer, J. P. (2000). Characterization of the mouse and human PRSS17 genes, their relationship to other serine proteases, and the expression of PRSS17 in developing mouse incisors. Gene 251, 1-8.
44. Huang, W., Shostak, Y., Tarr, P., Sawyers, C., and Carey, M. (1999). Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J. Biol. Chem. 274, 25756-25768.
45. Iwamura, M., Hellman, J., Cockett, A. T., LiIja, H. and Gershagen, S. (1996). Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen. Urology 48, 317-325.
46. Katz, B. A., Liu, B., Barnes, M. and Springman, E. B. (1998). Crystal structure of recombinant human tissue kallikrein at 2.0 Å resolution. Protein Sci. 7, 875-885.
47. Khan, A. R., and James, M. N. (1998). Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci. 7, 815-836.
48. Killian, C. S., Corral, D. A., Kawinski, E., and Constantine, R. I. (1993). Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-β and a proteolytic modulation of cell adhesion receptors. Biochem. Biophys. Res. Commun. 192, 940-947.
49. Kim, H., Scorilas, A., Katsaros, D., Yousef, G. M., Massobrio, M., Fracchioli, S., Piccinno, R., Gordini, G. and Diamandis, E. P. (2001). Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br. J. Cancer 84, 643-650.
50. Korkmaz, K. S., Korkmaz, C. G., Pretlow, T. G. and Saatcioglu, F. (2001). Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and regulation by multiple hormones. DNA Cell Biol. 20, 435-445.
51. Kumar, A., Mikolajczyk, S. D., Goel, A. S., Millar, L. S. and Saedi, M. S. (1997). Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res. 57, 3111-3114.
52. Lilja, H. (1985). A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest. 76, 1899-1903.
53. Little, S. P., Dixon, E. P., Norris, F., Buckley, W., Becker, G. W., Johnson, M., Dobbins, J. R., Wyrick, T., Miller, J. R., MacKellar, W. et al. (1997). Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J. Biol. Chem. 272, 25135-25142.
54. Liu, X. L., Wazer, D. E., Watanabe, K., and Band, V. (1996). Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56, 3371-3379.
55. Lovgren, J., Rajakoski, K., Karp, M., Lundwall, A., and Lilja, H. (1997). Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Blochem. Biophys. Res. Commun. 238, 549-555.
56. 2+ and extracellular protease inhibitors. Eur. J. Biochem. 262, 781-789.
57. Lundwall, A. (1989). Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem. Biophys. Res. Commun. 161, 1151-1159.
58. Luo, L., Herbrick, J. A., Scherer, S. W., Beatty, B., Squire, J., and Diamandis, E. P. (1998). Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem. Biophys. Res. Commun. 247, 580-586.
59. Luo, L., Bunting, P., Scorilas, A., and Diamandis, E. P. (2001a). Human kallikrein 10: a novel tumor marker for ovarian carcinoma? Clin. Chim. Acta 306, 111-118.
60. Luo, L. Y., Grass, L., Howarth, D. J., Thibault, R., Ong, H., and Diamandis, E. P. (2001b). Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin. Chem. 47, 237-246.
61. Luo, L. Y., Katsaros, D., Scorilas, A., Fracchioli, S., Piccinno, R., Rigault de la Longrais, I. A., Howarth, D. J., and Diamandis, E. P. (2001c). Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin. Cancer Res. 7, 2372-2379.
62. Luo, L. Y., Rajpert-De Meyts, E. R., Jung, K., and Diamandis, E. P. (2001d). Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br. J. Cancer 85, 220-224.
63. Macfarlane, S. R., Seatter, M. J., Kanke, T., Hunter, G. D. and Plevin, R. (2001). Proteinase-activated receptors. Pharmacol. Rev. 53, 245-282.
64. Magklara, A., Scorilas, A., Katsaros, D., Massobrio, M., Yousef, G. M., Fracchioli, S., Danese, S. and Diamandis, E. P. (2001). The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin. Cancer Res. 7, 806-811.
65. Margolius, H. S. (1998). Tissue kallikreins: structure, regulation, and participation in mammalian physiology and disease. Clin. Rev. Allergy Immunol. 16, 337-349.
66. Mason, A. J., Evans, B. A., Cox, D. R., Shine, J. and Richards, R. I. (1983). Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature 303, 300-307.
67. Matsui, H. and Takahashi, T. (2001). Mouse testicular leydig cells express klk21, a tissue kallikrein that cleaves fibronectin and igf-binding protein-3. Endocrinology 142, 4918-4929.
68. Mitsui, S., Tsuruoka, N., Yamashiro, K., Nakazato, H. and Yamaguchi, N. (1999). A novel form of human neuropsin, a brain-related serine protease, is generated by alternative splicing and is expressed preferentially in human adult brain. Eur. J. Biochem. 260, 627-634.
69. Mitsui, S., Okui, A., Kominami, K., Uemura, H. and Yamaguchi, N. (2000a). cDNA cloning and tissue-specific splicing variants of mouse hippostasin/TLSP (PRSS20). Biochim. Biophys. Acta 1494, 206-210.
70. Mitsui, S., Yamada, T., Okui, A., Kominami, K., Uemura, H. and Yamaguchi, N. (2000b). A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate. Biochem. Biophys. Res. Commun. 272, 205-211.
71. Murray, S. R., Chao, J., Lin, F. K. and Chao, L. (1990). Kallikrein multigene families and the regulation of their expression. J. Cardiovasc. Pharmacol. 15, S7-S16.
72. Murtha, P., Tindall, D. J. and Young, C. Y. (1993). Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry 32, 6459-6464.
73. Myers, S. A. and Clements, J. A. (2001). Kallikrein 4 (KLK4), a new member of the human kallikrein gene family is up-regulated by estrogen and progesterone in the human endometrial cancer cell line, KLE. J. Clin. Endocrinol. Metab. 86, 2323-2326.
74. Nakamura, T., Mitsui, S., Okui, A., Kominami, K., Nomoto, T., Miki, T. and Yamaguchi, N. (2001). Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines. Prostate, in press.
75. Nelson, R. S., Gan, L., Ferguson, C., Moss, P., Gelinas, R., Hood, L., and Wang, K. (1999). Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc. Natl. Acad. Sci. USA 96, 3114-3119.
76. Obiezu, C. V. and Diamandis, E. P. (2000). An alternatively spliced variant of KLK4 expressed in prostatic tissue. Clin. Biochem. 33, 599-600.
77. Obiezu, C. V., Scorilas, A., Katsaros, D., Massobrio, M., Yousef, G. M., Fracchioli, S., Rigault De La Longrais, I. A., Arisio, R. and Diamandis, E. P. (2001). Higher human kallikrein gene 4 (klk4) expression indicates poor prognosis of ovarian cancer patients. Clin. Cancer Res. 7, 2380-2386.
78. Pang, S., Dannull, J., Kaboo, R., Xie, Y., Tso, C. L., Michel, K., deKernion, J. B. and Belldegrun, A. S. (1997). Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. Cancer Res. 57, 495-499.
79. Partin, A. W., Catalona, W. J., Finlay, J. A., Darte, C., Tindall, D. J., Young, C. Y., Klee, G. G., Chan, D. W., Rittenhouse, H. G., Wolfert, R. L. and Woodrum, D. L. (1999). Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis. Urology 54, 839-845.
80. Petraki, C. D., Karavana, V. N., Skoufogiannis, P. T., Little, S. P., Howarth, D. J., Yousef, G. M. and Diamandis, E. P. (2001). The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J. Histochem. Cytochem. 49, 1431-1441.
81. Riegman, P. H., Klaassen, P., van der Korput, J. A., Romijn, J. C. and Trapman, J. (1988). Molecular cloning and characterization of novel prostate antigen cDNA's. Biochem. Biophys. Res. Commun. 155, 181-188.
82. Riegman, P. H., Vlietstra, R. J., Klaassen, P., van der Korput, J. A., Geurts van Kessel, A., Romijn, J. C. and Trapman, J. (1989a). The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19. FEBS Left. 247, 123-126.
83. Riegman, P. H., Vlietstra, R. J., van der Korput, J. A., Romijn, J. C. and Trapman, J. (1989b). Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem. Biophys. Res. Commun. 159, 95-102.
84. Riegman, P. H., Vlietstra, R. J., van der Korput, H. A., Romijn, J. C. and Trapman, J. (1991a). Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. Mol. Cell Endocrinol. 76, 181-190.
85. Riegman, P. H., Vlietstra, R. J., van der Korput, J. A., Brinkmann, A. O. and Trapman, J. (1991b). The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol. 5, 1921-1930.
86. Rittenhouse, H. G., Finlay, J. A., Mikolajczyk, S. D. and Partin, A. W. (1998). Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci. 35, 275-368.
87. Robert, M., Gibbs, B. F., Jacobson, E. and Gagnon, C. (1997). Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I. Biochemistry 36, 3811-3819.
88. Schachter, M. (1979). Kallikreins (kininogenases) - a group of serine proteases with bioregulatory actions. Pharmacol. Rev. 31, 1-17.
89. Schedlich, L. J., Bennetts, B. H. and Morris, B. J. (1987). Primary structure of a human glandular kallikrein gene. DNA 6, 429-437.
90. Schultz, R. M. and Liebman, M. N. (1997). Structure-function relationship in protein families. In: Textbook of Biochemistry with Clinical Correlations, T. M. Devlin, ed. (New York, USA: Wiley-Liss, Inc.), pp. 1-2-116.
91. Schuur, E. R., Henderson, G. A., Kmetec, L. A., Miller, J. D., Lamparski, H. G. and Henderson, D. R. (1996). Prostate-specific antigen expression is regulated by an upstream enhancer. J. Biol. Chem. 271, 7043-7051.
92. Silverthorn, D. U. (1995). Human physiology. An integrated aproach (New Jersy, USA: Prentice Hall).
93. Slawin, K. M., Shariat, S. F., Nguyen, C., Leventis, A. K., Song, W., Kattan, M. W., Young, C. Y., Tindall, D. J. and Wheeler, T. M. (2000). Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein. Cancer Res. 60, 7142-7148.
94. Smyth, M. J. (1998). Starum corneum chymotryptic enzyme. In Handbook of Proteolytic Enzymes, A. J. Barrett, and J. F. Woessner, eds. (London, UK: Academic Press), pp. 87-89.
95. Southan, C. (2001). A genomic perspective on human proteases as drug targets. Drug Discov. Today 6, 681-688.
96. Stephan, C., Jung, K., Lein, M., Sinha, P., Schnorr, D. and Loening, S. A. (2000). Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 9, 1133-1147.
97. Stephenson, S. A., Verity, K., Ashworth, L. K. and Clements, J. A. (1999). Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4. J. Biol. Chem. 274, 23210-23214.
98. Sutherland, G. R., Baker, E., Hyland, V. J., Callen, D. F., Close, J. A., Tregear, G. W., Evans, B. A. and Richards, R. I. (1988). Human prostate-specific antigen (APS) is a member of the glandular kallikrein gene family at 19q13. Cytogenet. Cell. Genet. 48, 205-207.
99. Sutkowski, D. M., Goode, R. L., Baniel, J., Teater, C., Cohen, P., McNulty, A. M., Hsiung, H. M., Becker, G. W. and Neubauer, B. L. (1999). Growth regulation of prostatic stromal cells by prostate-specific antigen. J. Natl. Cancer Inst. 91, 1663-1669.
100. Takayama, T. K., Fujikawa, K. and Davie, E. W. (1997). Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem. 272, 21582-21588.
101. Takayama, T. K., Carter, C. A. and Deng, T. (2001 a). Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR. Biochemistry 40, 1679-1687.
102. Takayama, T. K., McMullen, B. A., Nelson, P. S., Matsumura, M. and Fujikawa, K. (2001b). Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Biochemistry 40, 15341-15348.
103. Tanaka, T., Isono, T., Yoshiki, T., Yuasa, T. and Okada, Y. (2000). A novel form of prostate-specific antigen transcript produced by alternative splicing. Cancer Res. 60, 56-59.
104. Tanimoto, H., Underwood, L. J., Shigemasa, K., Yan Yan, M. S., Clarke, J., Parmley, T. H. and O'Brien, T. J. (1999). The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer 86, 2074-2082.
105. Trapman, J. and Cleutjens, K. B. (1997). Androgen-regulated gene expression in prostate cancer. Semin. Cancer Biol. 8, 29-36.
106. Underwood, L. J., Tanimoto, H., Wang, Y., Shigemasa, K., Parmley, T. H. and O'Brien, T. J. (1999). Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res. 59, 4435-4439.
107. van Leeuwen, B. H., Evans, B. A., Tregear, G. W. and Richards, R. I. (1986). Mouse glandular kallikrein genes. Identification, structure, and expression of the renal kallikrein gene. J. Biol. Chem. 261, 5529-5535.
108. Wines, D. R., Brady, J. M., Pritchett, D. B., Roberts, J. L. and MacDonald, R. J. (1989). Organization and expression of the rat kallikrein gene family. J. Biol.Chem. 264, 7653-7662.
109. Yamashiro, K., Tsuruoka, N., Kodama, S., Tsujimoto, M., Yamamura, Y., Tanaka, T., Nakazato, H. and Yamaguchi, N. (1997). Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim. Biophys. Acta 1350, 11-14.
110. Yoshida, S., Taniguchi, M., Hirata, A. and Shiosaka, S. (1998a). Sequence analysis and expression of human neuropsin cDNA and gene. Gene 213, 9-16.
111. Yoshida, S., Taniguchi, M., Suemoto, T., Oka, T., He, X. and Shiosaka, S. (1998b). cDNA cloning and expression of a novel serine protease, TLSP Biochim. Biophys. Acta 1399, 225-228.
112. Yousef, G. M. and Diamandis, E. P. (1999). The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. J. Biol. Chem. 274, 37511-37516.
113. Yousef, G. M. and Diamandis, E. P. (2000). The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics 65, 184-194.
114. Yousef, G. M. and Diamandis, E. P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184-204.
115. Yousef, G. M. and Diamandis, E. P. (2002). Human kallikreins: common structural features, sequence analysis and evolution. Curr. Genomics, in press.
116. Yousef, G. M., Luo, L. Y., and Diamandis, E.P. (1999a). Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res. 19, 2843-2852.
117. Yousef, G. M., Luo, L. Y., Scherer, S. W., Sotiropoulou, G. and Diamandis, E. P. (1999b). Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. Genomics 62, 251-259.
118. Yousef, G. M., Obiezu, C. V., Luo, L. Y., Black, M. H. and Diamandis, E. P. (1999c). Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. Cancer Res. 59, 4252-4256.
119. Yousef, G. M., Scorilas A., and Diamandis E. P. (2000a). Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics 63, 88-96.
120. Yousef, G. M., Chang, A. and Diamandis, E. P. (2000b). Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. J. Biol. Chem. 275, 11891-11898.
121. Yousef, G. M., Chang, A., Scorilas, A. and Diamandis, E. P. (2000c). Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 276, 125-133.
122. Yousef, G. M., Magklara, A. and Diamandis, E. P. (2000d). KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer. Genomics 69, 331-341.
123. Yousef, G. M., Scorilas, A. and Diamandis, E. P. (2000e). Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics 63, 88-96.
124. Yousef, G. M., Scorilas, A., Magklara, A., Soosaipillai, A. and Diamandis, E. p. (2000f). The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation. Gene 254, 119-128.
125. Yousef, G. M., Kyriakopoulou, L. G., Scorilas, A., Fracchioli,,S., Ghiringhello, B., Zarghooni, M., Chang, A., Diamandis, M., Giardina, G., Hartwick, W. J., Richiardi, G., Massobrio, M., Diamandis, E. P. and Katsaros, D. (2001a). Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res. 61, 7811-7818.
126. Yousef, G. M., Magklara, A., Chang, A., Jung, K., Katsaros, D. and Diamandis, E. P. (2001b). Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res. 61, 3425-3431.
127. Yousef, G. M., Scorilas, A., Jung, K., Ashworth, L. K. and Diamandis, E. P. (2001c). Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J. Biol. Chem. 276, 53-61.
128. Yousef, G. M., Obiezu, C., Jung, K., Stephan, C., Scorilas, A. and Diamandis, E. P. (2002a). Differetial expression of kallikrein gene 5 (KLK5) in cancerous and normal testicular tissues. Urology, in press.
129. Yousef, G. M., Scorilas, A., Chang, A., Rendl, L., Diamandis, M., Jung, K. and Diamandis, E. P. (2002b). Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. Prostate, in press.
130. Yousef, G. M., Scorilas, A., Kyriakopoulou, L. G., Rendl, L., Diamandis, M., Ponzone, R., Biglia, N., Giai, M., Roagna, R., Sismondi, P. and Diamandis, E. P. (2002c). Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin. Chem., in press.
131. Yu, D. C., Sakamoto, G. T. and Henderson, D. R. (1999). Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. Cancer Res. 59, 1498-1504.